CLIAC was established under Section 222 of the Public Health Service Act [42 USC 217a], as
amended. The Committee is governed by the provisions of the Federal Advisory Committee Act, as amended,
5 USC App., which sets forth standards for the formation and use of advisory committees.
By providing scientific and technical advice and guidance to CDC, CMS, and FDA, the Committee supports the Secretary, HHS’ authority under the Clinical Laboratory Improvement Amendments (CLIA) to
establish quality standards to assure consistent performance of accurate and reliable testing in sites that perform testing for the diagnosis, prevention, or treatment of disease or the
assessment of human health.